keyword
https://read.qxmd.com/read/38617385/effect-of-intraoperative-opioid-dose-on-perioperative-neutrophil-to-lymphocyte-ratio-and-lymphocyte-to-monocyte-ratio-in-glioma
#1
JOURNAL ARTICLE
Xuejiao Liu, Lei Teng, Junzhu Dai, Hongxue Shao, Rui Chen, Haixiang Li, Jing Li, Huichao Zou
BACKGROUND: The neutrophil-to-lymphocyte ratio (NLR) and lymphocyte-to-monocyte ratio (LMR) are inflammatory biomarkers. Until now, it is unknown the impact of opioid dosage on perioperative immunity in glioma patients. The aim of this study was to explore the effect of intraoperative opioid dosage on perioperative immune perturbations using NLR and LMR as inflammatory biomarkers and evaluate the correlation between inflammatory biomarkers and pathological grade of glioma. METHODS: The study included 208 patients with primary glioma who underwent glioma resection from February 2012 to November 2019 at Harbin Medical University Cancer Hospital...
2024: Journal of Inflammation Research
https://read.qxmd.com/read/38614853/impact-of-preoperative-plasma-potassium-levels-on-oncological-outcomes-major-complications-and-30-day-mortality-in-bladder-cancer-patients-undergoing-radical-cystectomy
#2
JOURNAL ARTICLE
Jakob Klemm, Shahrokh F Shariat, Ekaterina Laukhtina, Pawel Rajwa, Malte W Vetterlein, Victor M Schuettfort, Markus von Deimling, Roland Dahlem, Margit Fisch, Michael Rink
INTRODUCTION AND OBJECTIVES: We examined the impact of preoperative plasma potassium levels (PPLs) on outcomes in patients undergoing radical cystectomy (RC) for urothelial carcinoma of the bladder (UCB), hypothesizing that potassium imbalances might influence outcomes. PATIENTS AND METHODS: In this retrospective study, 501 UCB patients undergoing RC from 2009 to 2017 at a tertiary center were analyzed. Blood samples collected a week prior to surgery defined normal and abnormal PPL based on institutional standards...
March 21, 2024: Clinical Genitourinary Cancer
https://read.qxmd.com/read/38610980/an-updated-review-of-management-of-resectable-stage-iii-nsclc-in-the-era-of-neoadjuvant-immunotherapy
#3
REVIEW
Saurav Verma, Daniel Breadner, Abhenil Mittal, David A Palma, Rahul Nayak, Jacques Raphael, Mark Vincent
Immune-checkpoint inhibitors (ICIs) have an established role in the treatment of locally advanced and metastatic non-small cell lung cancer (NSCLC). ICIs have now entered the paradigm of early-stage NSCLC. The recent evidence shows that the addition of ICI to neoadjuvant chemotherapy improves the pathological complete response (pCR) rate and survival rate in early-stage resectable NSCLC and is now a standard of care option in this setting. In this regard, stage III NSCLC merits special consideration, as it is heterogenous and requires a multidisciplinary approach to management...
March 27, 2024: Cancers
https://read.qxmd.com/read/38610685/perioperative-ketamine-and-cancer-recurrence-a-comprehensive-review
#4
REVIEW
Juan Alberto Rodriguez Arango, Tamara Zec, Maher Khalife
Cancer is a significant global health threat and a leading cause of death worldwide. Effective early-stage interventions, particularly surgery, can potentially cure many solid tumors. However, the risk of postoperative cancer recurrence remains high. Recent research highlights the influence of perioperative anesthetic and analgesic choices on the fate of residual cancer cells, potentially affecting recurrence risks. Among these agents, ketamine-a well-known anesthetic and analgesic-has garnered interest due to its antitumor properties, mainly through inhibiting the N-methyl-D-aspartate (NMDA) receptor found in various cancer tissues...
March 26, 2024: Journal of Clinical Medicine
https://read.qxmd.com/read/38592265/postoperative-myocardial-infarction-after-non-cardiac-surgery-an-update
#5
REVIEW
Carlo Rostagno, Anna Craighero
Every year, not less than 300 million non-cardiac surgery interventions are performed in the world. Perioperative mortality after non-cardiac surgery is estimated at 2% in patients over 45 years of age. Cardiovascular events account for half of these deaths, and most are due to perioperative myocardial infarction (MINS). The diagnosis of postoperative myocardial infarction, before the introduction of cardiac biomarkers, was based on symptoms and electrocardiographic changes and its incidence was largely underestimated...
March 4, 2024: Journal of Clinical Medicine
https://read.qxmd.com/read/38589856/a-phase-ii-iii-randomized-clinical-trial-of-cisplatin-plus-gemcitabine-and-nabpaclitaxel-gap-as-preoperative-chemotherapy-versus-immediate-resection-in-patients-with-resectable-biliary-tract-cancers-btc-at-high-risk-for-recurrence-purity-study
#6
RANDOMIZED CONTROLLED TRIAL
Monica Niger, Federico Nichetti, Lorenzo Fornaro, Chiara Pircher, Federica Morano, Federica Palermo, Lorenza Rimassa, Tiziana Pressiani, Rossana Berardi, Andrea Casadei Gardini, Elisa Sperti, Lisa Salvatore, Davide Melisi, Francesca Bergamo, Salvatore Siena, Stefania Mosconi, Raffaella Longarini, Giuseppina Arcangeli, Salvatore Corallo, Laura Delliponti, Stefano Tamberi, Elena Fea, Giovanni Brandi, Ilario Giovanni Rapposelli, Massimiliano Salati, Paolo Baili, Rosalba Miceli, Silva Ljevar, Ilaria Cavallo, Elisa Sottotetti, Antonia Martinetti, Michele Droz Dit Busset, Carlo Sposito, Maria Di Bartolomeo, Filippo Pietrantonio, Filippo de Braud, Vincenzo Mazzaferro
BACKGROUND: Biliary tract cancers (BTCs) are rare and lethal cancers, with a 5-year survival inferior to 20%(1-3). The only potential curative treatment is surgical resection. However, despite complex surgical procedures that have a remarkable risk of postoperative morbidity and mortality, the 5-year survival rate after radical surgery (R0) is 20-40% and recurrence rates are up to ~ 75%(4-6). Up to ~ 40% of patients relapse within 12 months after resection, and half of these patient will recur systemically(4-6)...
April 8, 2024: BMC Cancer
https://read.qxmd.com/read/38580363/hepato-p-ancreaticobiliary-r-esection-arginine-i-mmuno-m-odulation-prime-trial-protocol-for-a-randomised-phase-ii-trial-of-the-impact-of-perioperative-immunomodulation-on-immune-function-following-resection-for-hepatopancreaticobiliary-malignancy
#7
JOURNAL ARTICLE
Ramy Behman, Rebecca C Auer, Lev Bubis, Grace Xu, Natalie G Coburn, Guillaume Martel, Julie Hallet, Fady Balaa, Calvin Law, Kimberly A Bertens, Jad Abou Khalil, Paul Jack Karanicolas
INTRODUCTION: Surgical stress results in immune dysfunction, predisposing patients to infections in the postoperative period and potentially increasing the risk of cancer recurrence. Perioperative immunonutrition with arginine-enhanced diets has been found to potentially improve short-term and cancer outcomes. This study seeks to measure the impact of perioperative immunomodulation on biomarkers of the immune response and perioperative outcomes following hepatopancreaticobiliary surgery...
April 5, 2024: BMJ Open
https://read.qxmd.com/read/38576390/prognostic-and-predictive-biomarkers-with-therapeutic-targets-in-nonsmall-cell-lung-cancer-a-2023-update-on-current-development-evidence-and-recommendation
#8
JOURNAL ARTICLE
Clement Chung, Godsfavour Umoru
BACKGROUND: Since the publication of the original work in 2014, significant progress has been made in the characterization of genomic alterations that drive oncogenic addiction of nonsmall cell lung cancer (NSCLC) and how the immune system can leverage non-oncogenic pathways to modulate therapeutic outcomes. This update evaluates and validates the recent and emerging data for prognostic and predictive biomarkers with therapeutic targets in NSCLC. DATA SOURCES: We performed a literature search from January 2015 to October 2023 using the keywords non-small cell lung cancer , clinical practice guidelines , gene mutations , genomic assay , immune cancer therapy , circulating tumor DNA , predictive and prognostic biomarkers , and targeted therapies ...
April 5, 2024: Journal of Oncology Pharmacy Practice
https://read.qxmd.com/read/38573839/association-between-the-lung-microbiome-and-perioperative-prognosis-in-lung-transplantat-recipients
#9
JOURNAL ARTICLE
Yuhan Wu, Linna Huang, Min Li, Xiaoyang Cui, Jun Zhu, Qingyuan Zhan, Chen Wang
RATIONALE: Studies have confirmed that the lung microbiome of lung transplant recipients is altered and serves as a prognostic indicator for long-term mortality. Other studies reported that the lung microbiome affects host immunity and the transcriptome. However, the lung microbiome composition at the early post-transplant period following lung transplantation is unclear, and the relationship of the lung microbiome with pulmonary immunity and the host transcriptome is also not well understood...
April 4, 2024: Journal of Applied Microbiology
https://read.qxmd.com/read/38570300/outcomes-reported-in-randomised-trials-of-surgical-prehabilitation-a-scoping-review
#10
REVIEW
Chloé Fleurent-Grégoire, Nicola Burgess, Linda Denehy, Lara Edbrooke, Dominique Engel, Giuseppe Dario Testa, Julio F Fiore, Daniel I McIsaac, Stéphanie Chevalier, John Moore, Michael P Grocott, Robert Copeland, Denny Levett, Celena Scheede-Bergdahl, Chelsia Gillis
BACKGROUND: Heterogeneity of reported outcomes can impact the certainty of evidence for prehabilitation. The objective of this scoping review was to systematically map outcomes and assessment tools used in trials of surgical prehabilitation. METHODS: MEDLINE, EMBASE, PsychInfo, Web of Science, CINAHL, and Cochrane were searched in February 2023. Randomised controlled trials of unimodal or multimodal prehabilitation interventions (nutrition, exercise, psychological support) lasting at least 7 days in adults undergoing elective surgery were included...
April 2, 2024: British Journal of Anaesthesia
https://read.qxmd.com/read/38556145/inhaled-nitric-oxide-and-postoperative-outcomes-in-cardiac-surgery-during-cardiopulmonary-bypass-a-systematic-review-and-meta-analysis
#11
JOURNAL ARTICLE
Yun Yan, Nikolay Kamenshchikov, Ziyu Zheng, Chong Lei
Cardiac surgeries under cardiopulmonary bypass (CPB) are complex procedures with high incidences of complications, morbidity and mortality. The inhaled nitric oxide (iNO) has been frequently used as an important composite of perioperative management during cardiac surgery under CPB. We conducted a meta-analysis of published randomized clinical trials (RCTs) to assess the effects of iNO on reducing postoperative complications, including the duration of postoperative mechanical ventilation, length of intensive care unit (ICU) stay, length of hospital stay, mortality, hemodynamic improvement (the composite right ventricular failure, low cardiac output syndrome, pulmonary arterial pressure, and vasoactive inotropic score) and myocardial injury biomarker (postoperative troponin I levels)...
March 29, 2024: Nitric Oxide: Biology and Chemistry
https://read.qxmd.com/read/38547046/the-use-of-biomarkers-to-quantify-clinical-response-to-total-knee-arthroplasty-interventions-a-systematic-review
#12
JOURNAL ARTICLE
Mark Mackie, Kristen I Barton, Darek Sokol-Randell, Brent Lanting
The primary objective of this review was to determine whether the attenuation of the postoperative inflammatory response (PIR) after total knee arthroplasty (TKA) leads to a notable improvement in clinical outcome scores. The secondary objective of this review was to determine the optimal approach in using inflammatory biomarkers, clinical inflammatory assessments, and imaging to quantify the PIR. A systematic literature search of eight major databases was conducted using a predetermined search strategy. C-reactive protein (CRP), interleukin-6 (IL-6), erythrocyte sedimentation rate (ESR), knee surface temperature (KST), and clinical outcome data were collected and graphically displayed...
April 1, 2024: Journal of the American Academy of Orthopaedic Surgeons. Global Research & Reviews
https://read.qxmd.com/read/38541208/pd-l1-expression-and-tumour-microenvironment-patterns-in-resected-non-small-cell-lung-cancer
#13
JOURNAL ARTICLE
Giedrė Gurevičienė, Jurgita Matulionė, Lina Poškienė, Skaidrius Miliauskas, Marius Žemaitis
Background and Objectives : Although perioperative immunotherapy is implemented as a standard of care for resected non-small cell lung cancer (NSCLC), there is unmet need for predictive biomarkers as programmed death-ligand 1 (PD-L1) is not the perfect one. The functionality of tumour-infiltrating immune cells in the tumour microenvironment (TME) and the involvement in immune system response is one of the crucial factors that lead to pro- or anti-tumourigenic role and could predict response to PD-1 and PD-L1 inhibitors...
March 14, 2024: Medicina
https://read.qxmd.com/read/38537973/the-crp-albumin-lymphocyte-cally-index-is-an-independent-prognostic-factor-for-gastric-cancer-patients-who-receive-curative-treatment
#14
JOURNAL ARTICLE
Toru Aoyama, Yukio Maezawa, Itaru Hashimoto, Kentaro Hara, Ayako Tamagawa, Keusike Kazama, Aya Kato, Haruhiko Cho, Masato Nakazono, Masakatsu Numata, Shinnosuke Kawahara, Mie Tanabe, Jyunya Morita, Takashi Oshima, Aya Saito, Norio Yukawa, Yasushi Rino
BACKGROUND/AIM: The CRP-albumin-lymphocyte (CALLY) index is a promising biomarker. We clarified the clinical impact of the CALLY index in gastric cancer patients who received curative treatment. PATIENTS AND METHODS: Consecutive patients who underwent curative resection for gastric cancer at Yokohama City University from 2005 to 2020 were selected based on medical records. The CALYY index was calculated as follows: serum ALB level (g/dl) × lymphocyte count (cells/μl)/C-reactive protein (mg/dl) ×104 Results: Two hundred fifty-nine patients were included in the present study...
April 2024: Anticancer Research
https://read.qxmd.com/read/38537954/clinical-impact-of-nutrition-and-inflammation-assessment-tools-in-colorectal-cancer-treatment
#15
REVIEW
Toru Aoyama, Norio Yukawa, Aya Saito
For resectable colorectal cancer (CRC), the standard treatment is perioperative adjuvant treatment and complete resection. For unresectable CRC, the standard treatment is systemic chemotherapy. The detection of promising biomarkers is necessary for optimizing the management of CRC and improving patient survival. If physicians can detect useful biomarkers, patients with CRC may benefit from more aggressive or less toxic treatment. Recent studies have shown that the inflammatory and nutritional status both influence the short and long-term oncological outcomes of patients with CRC during perioperative and/or chemotherapy...
April 2024: Anticancer Research
https://read.qxmd.com/read/38537904/perioperative-hyperoxia-impact-on-myocardial-biomarkers-strain-and-outcome-in-high-risk-patients-undergoing-non-cardiac-surgery-protocol-for-a-prospective-randomized-controlled-trial
#16
JOURNAL ARTICLE
Jan O Friess, Sandra Stiffler, Jan Mikasi, Gabor Erdoes, Michael Nagler, Christoph Gräni, Salome Weiss, Kady Fischer, Dominik P Guensch
BACKGROUND: Supplemental oxygen is used during every general anesthesia. However, for the maintenance phase of a general anesthesia, in most cases the longest part of anesthesia, only scarce evidence of dosing supplemental oxygen exists. Oxygen is a well-known coronary vasoconstrictor and thus may contribute to cardiovascular complications especially in vulnerable high-risk patients with coronary artery disease undergoing major non-cardiac surgery. Myocardial biomarkers are early indicators of myocardial injury...
March 25, 2024: Contemporary Clinical Trials
https://read.qxmd.com/read/38522144/effects-of-esketamine-on-postoperative-negative-emotions-and-early-cognitive-disorders-in-patients-undergoing-non-cardiac-thoracic-surgery-a-randomized-controlled-trial
#17
JOURNAL ARTICLE
Tianyuan Luo, Zhimin Deng, Qiyang Ren, Fangfang Mu, You Zhang, Haiying Wang
STUDY OBJECTIVE: To investigate whether a single dosage of esketamine injection in the anesthesia period could improve postoperative negative emotions and early cognitive function in patients undergoing non-cardiac thoracic surgery. DESIGN: A prospective single center double blinded randomized placebo-controlled trial. SETTING: Perioperative period; operating room, post anesthesia care unit and hospital ward. PATIENTS: 129 adult patients that underwent elective non-cardiac thoracic surgery under general anesthesia...
March 23, 2024: Journal of Clinical Anesthesia
https://read.qxmd.com/read/38505191/perioperative-treatment-with-rivaroxaban-and-dabigatran-on-changes-of-coagulation-and-platelet-activation-biomarkers-following-left-atrial-appendage-closure
#18
JOURNAL ARTICLE
Yao Yao, Yanli Li, Qinchun Jin, Xiaoye Li, Xiaochun Zhang, Qianzhou Lv
Insufficient data exist regarding the investigation of the impact of novel oral anticoagulants (NOACs) on coagulation activation biomarkers in the context of left atrial appendage closure (LAAC) and device-related thrombosis (DRT). The study was designed to investigate the changes and presence of coagulation activation biomarkers between different antithrombotic strategies following LAAC. A total of 120 nonvalvular atrial fibrillation patients intolerant of long-term anticoagulants, who underwent successful WATCHMAN closure implantation, were enrolled (rivaroxaban, n = 82; dabigatran, n = 38)...
2024: Cardiovascular Therapeutics
https://read.qxmd.com/read/38503041/gastroesophageal-adenocarcinomas-with-defective-mismatch-repair-current-knowledge-and-clinical-management
#19
REVIEW
Matthew R Strickland, Eric M Lander, Michael K Gibson, David H Ilson, Jaffer A Ajani, Samuel J Klempner
Esophageal, gastroesophageal junction, and gastric adenocarcinomas, referred to collectively as gastroesophageal adenocarcinomas (GEAs), are a major cause of global cancer-related mortality. Our increasing molecular understanding has led to the addition of biomarker-directed approaches to defined subgroups and has improved survival in selected patients, such as those with HER2 and Claudin18.2 overexpression. Immune checkpoint inhibitors (ICIs) have revolutionized the treatment of cancer, including GEA, but biomarkers beyond PD-L1 expression are lacking...
March 19, 2024: Journal of the National Comprehensive Cancer Network: JNCCN
https://read.qxmd.com/read/38496400/an-immune-signature-of-postoperative-cognitive-decline-in-elderly-patients
#20
Franck Verdonk, Amélie Cambriel, Julien Hedou, Ed Ganio, Grégoire Bellan, Dyani Gaudilliere, Jakob Einhaus, Maximilian Sabayev, Ina A Stelzer, Dorien Feyaerts, Adam T Bonham, Kazuo Ando, Benjamin Choisy, David Drover, Boris Heifets, Fabrice Chretien, Nima Aghaeepour, Martin S Angst, Serge Molliex, Tarek Sharshar, Raphael Gaillard, Brice Gaudilliere
UNLABELLED: Postoperative cognitive decline (POCD) is the predominant complication affecting elderly patients following major surgery, yet its prediction and prevention remain challenging. Understanding biological processes underlying the pathogenesis of POCD is essential for identifying mechanistic biomarkers to advance diagnostics and therapeutics. This longitudinal study involving 26 elderly patients undergoing orthopedic surgery aimed to characterize the impact of peripheral immune cell responses to surgical trauma on POCD...
March 5, 2024: bioRxiv
keyword
keyword
119877
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.